Ulcerative colitis trials in China

In China 67 Also abroad 381

16 of 67 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Where
Beijing, Changzhou, Guangzhou, Hangzhou, Nanjing, Shenzhen, Shijiazhuang, Tianjin
Age
18 years and over
People
200
Run by
Xian-Janssen Pharmaceutical Ltd.
See details and how to joinNCT07302360
No phaseTaking people
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis
Where
Wenzhou
Age
18 years and over
People
97
Run by
Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07726888
No phaseTaking people
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Where
Foshan, Guangzhou, Shenzhen
Age
18 years and over
People
150
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07442045
No phaseTaking people
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
Where
Jinan
Age
18 years to 75 years
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07111273
No phaseTaking people
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
Where
Jinan
Age
18 years to 75 years
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07111572
No phaseEnrolling by invitation
Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）
Where
Beijing, Chongqing, Dalian, Nanjing, Qingdao, Shengyang, Shenzhen, Wuhan, Xi'an
Age
18 years and over
People
200
Run by
Tang-Du Hospital
See details and how to joinNCT07721441
No phaseNot yet taking people in China
A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC
Where
Xi'an
Age
18 years and over
People
500
Run by
Tang-Du Hospital
See details and how to joinNCT07705126
No phaseTaking people
IBD Biomarker Discovery and Validation Platform
Where
Guangzhou
Age
14 years and over
People
6,000
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07686406
No phaseTaking people
A Prospective Observational Study on the Efficacy and Safety of Guselkumab in the Treatment of Crohn's Disease Patients Previously Treated With Ustekinumab
Where
Hangzhou
Age
18 years to 75 years
People
60
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07487480
No phaseTaking people
Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD
Where
Hangzhou
Age
14 years to 80 years
People
300
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07385131
No phaseTaking people
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
Where
Xi'an
Age
18 years to 65 years
People
152
Run by
Xijing Hospital
See details and how to joinNCT06359808
No phaseTaking people
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
Where
Shanghai
Age
3 years and over
People
4,000
Run by
Chen QiYi
See details and how to joinNCT07261826
No phaseTaking people
An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)
Where
Guangzhou, Zhengzhou
Age
18 years and over
People
80
Run by
AbbVie
See details and how to joinNCT06838845
No phaseTaking people
Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis
Where
Shanxi
Age
18 years to 70 years
People
400
Run by
Xijing Hospital of Digestive Diseases
See details and how to joinNCT06962020
No phaseTaking people
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
Where
Xi'an
Age
18 years to 65 years
People
146
Run by
Xijing Hospital
See details and how to joinNCT06995170
No phaseTaking people
Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
Where
Guangzhou, Liuzhou, Meizhou, Nanning, Shenzhen
People
174
Run by
Xiang Gao
See details and how to joinNCT06780683